iRadimed Corporation (IRMD) To Go Ex-Dividend on August 14th

iRadimed Corporation (NASDAQ:IRMD) announced a quarterly dividend on Thursday, July 30th. Investors of record on Friday, August 14th will be given a dividend of 0.20 per share by the medical equipment provider on Friday, August 28th. This represents a c) dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, August 14th.

iRadimed has a dividend payout ratio of 40.2% meaning its dividend is sufficiently covered by earnings.

iRadimed Trading Down 1.5%

Shares of iRadimed stock opened at $88.94 on Wednesday. The stock has a 50 day moving average of $94.49 and a 200 day moving average of $95.16. iRadimed has a 12 month low of $67.84 and a 12 month high of $107.90. The firm has a market cap of $1.14 billion, a PE ratio of 49.69 and a beta of 0.90.

iRadimed (NASDAQ:IRMD) last released its quarterly earnings results on Friday, July 31st. The medical equipment provider reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.02. iRadimed had a return on equity of 23.45% and a net margin of 26.70%.The business had revenue of $20.47 million during the quarter, compared to analysts’ expectations of $20.35 million. iRadimed has set its FY 2026 guidance at 2.090-2.240 EPS and its Q3 2026 guidance at 0.540-0.590 EPS. As a group, equities research analysts forecast that iRadimed will post 1.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on IRMD. Wall Street Zen lowered shares of iRadimed from a “buy” rating to a “hold” rating in a report on Saturday. Weiss Ratings downgraded shares of iRadimed from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, August 3rd. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $120.00.

About iRadimed

iRadimed Corporation designs, develops and manufactures medical device solutions for MRI environments. The company’s core product line consists of MRI-compatible infusion systems engineered to deliver precise fluid management during magnetic resonance imaging procedures. These devices are crafted to minimize electrical noise and interference, ensuring both patient safety and image clarity in diagnostic and interventional settings.

In addition to infusion pumps, iRadimed offers a range of complementary accessories and monitoring solutions tailored to MRI suites.